US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

A 3D primary human cell-based in vitro model of non-alcoholic

CD352 (NTB-A) Antibody, anti-human, REAfinity™

Antibody-drug conjugates targeting CD248 inhibits liver fibrosis

Targeting CD301+ macrophages inhibits endometrial fibrosis and

In vivo imaging of prostate cancer using an anti-PSMA scFv

The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis

Adriamycin induces cardiac fibrosis in mice via PRMT5-mediated

Recombinant Alexa Fluor® 488 Anti-GAD65 antibody [EPR22952-70

US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5